Reuters: Money News: Glenmark gains on USFDA nod for diarrhoea drug

Reuters: Money News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Glenmark gains on USFDA nod for diarrhoea drug Jan 1st 2013, 08:38 Reuters Market Eye - Shares in Glenmark Pharmaceuticals gain 2.5 percent after U.S. health regulators approved Salix Pharmaceuticals Ltd's drug to treat diarrhoea in HIV/AIDS patients on qantiretroviral therapy, a combination of medicines used to treat HIV infection.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions